GOSS
Gossamer Bio Inc
10.70$
-10.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +641.7% | +53,702.0% | +78.2% | +26.4% | -36.3% | -20.7% | +14.5% | +1.1% | -45.4% | |
| – | +641.7% | +52,024.3% | +76.5% | +27.6% | -36.5% | -21.1% | +17.0% | +1.1% | -45.9% | |
| – | +425.0% | +33,302.9% | +28.3% | +260.0% | -62.3% | -38.9% | -71.3% | +43.5% | -18.1% | |
| – | +425.0% | +72,489.8% | +75.7% | +27.6% | -36.6% | -21.4% | +15.9% | -0.6% | -53.5% | |
| – | – | – | +200.0% | -86.7% | +0.0% | – | – | – | +134.7% | |
| – | – | – | – | – | -137.3% | – | – | – | – | |
| – | – | – | +392.6% | -64.8% | -3.9% | -25.2% | – | – | – | |
| – | +3,892.9% | +4,819.8% | -79.4% | +195.1% | +1.6% | +17.2% | -4.3% | +14.7% | +3.2% | |
| – | +785.3% | +1,511.6% | +81.0% | +4.7% | +3.1% | +23.5% | +4.8% | -12.8% | +40.9% | |
| – | – | – | – | +54.3% | -20.1% | +403.0% | +2.2% | -93.6% | -2.4% | |
| – | +142.5% | +2,149.5% | -56.2% | +685.4% | -56.8% | -55.0% | +278.8% | -58.0% | +157.0% | |
| – | +15,000.0% | – | – | +505.7% | +3.9% | +16.0% | -5.0% | +0.1% | +0.5% | |
| – | – | – | – | -9.0% | -62.1% | -90.1% | +419.7% | -53.0% | -516.2% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +171.1% | +143.2% | -9.4% | +25.2% | +9.2% | -98.6% | +80.5% | +48.2% | +1.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.